90

Business

Thumbs up for Novo Nordisk obesity drug

admin
September 12th, 2014


This article is more than 10 years old.

The decision is an important step towards its release in the US

The Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the American Food and Drug Administration (FDA) has voted in favour of approving Novo Nordisk’s new product Saxenda, a drug for the treatment of obesity, the company announced in a press release yesterday.

The panel voted in favour of the drug by a convincing 14 to 1, an important step in the process of getting the drug approved for sale in the lucrative American market.

“We are pleased with the clear recommendation from the advisory committee,” Mads Krogsgaard Thomsen, the company’s chief science officer, said in the press release.

Happy shareholders
“We look forward to working with the FDA as they complete their review of Saxenda. Obesity is a serious public health issue in the US and we are committed to making Saxenda a new treatment option for adults with obesity.”

Børsen reports that the news was also greeted favourably by the company’s shareholders, including the pension company PFA, which reportedly has 4.5 billion kroner at stake.

Jesper Langmack, the head of PFA, told Børsen that the share price has risen in expectation of FDA approval. “It will rise even more this morning,” he said. “So we’re of course very happy about the news, even though a no wouldn’t have changed our long-term view of Novo – just reduced potential in the share price.”

The new drug application (NDA) for Saxenda was submitted by Novo Nordisk to the FDA on 20 December 2013.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”